Colorectal Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Oct 1, 2004; 10(19): 2800-2804
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2800
Table 1 Comparison of ICAM-1 expression between colon cancer and normal colon (mean ± SD)
GroupCasesICAM-1/15HPF
Normal colon511.001 ± 1.58
Colon cancer3226.131 ± 9.19b
Table 2 ICAM-1 expression in colon cancer (mean ± SD)
Dukes stageCasesICAM-1
ICAM-1/15HPFP Value
Low-expressionHigh-expression
A53219.671 ± 5.59
B156923.571 ± 9.65
C103725.591 ± 8.07< 0.01
D20235.681 ± 2.51
Metastasis123928.091 ± 8.33
No metastasis2011922.621 ± 8.99
Table 3 Relationship between clinical pathological parameter and nm23H1 genetic instability in colon cancer (mean ± SD)
CasesMSI (%)LOH (%)nm23 (%)nm23 expression
Histological types308 (26.67)6 (20.00)16 (53.33)40.21 ± 3.29
Tubular adenocarcinoma257 (28.00)5 (20.00)15 (60.00)40.76 ± 2.74
High differentiation82 (25.00)1 (12.50)8 (100.00)41.49 ± 2.01
Intermediate differentiation135 (38.46)2 (15.38)6 (46.15)40.41 ± 1.98
Poor differentiation40 (0.00)2 (50.00)1 (25.00)d40.18 ± 2.17
Mucoid adenocarcinoma51 (20.00)1 (20.00)1 (20.00)b39.53 ± 2.61
TNM stage
Stage I + II167 (43.75)1 (6.25)13 (81.25)42.42 ± 1.08
Stage III + IV141 (7.14)e5 (35.71)e3 (21.43)f39.49 ± 2.57
Dukes stage
A52 (40.00)0 (0.00)4 (80.00)41.32 ± 2.18
B155 (33.33)3 (20.00)8 (53.33)40.69 ± 2.11
C81 (12.50)1 (12.50)4 (50.00)42.32 ± 1.66
D20 (0.00)2 (100.0)h0 (0.00)39.24 ± 2.32
Table 4 Relationship between LOH, MSI and nm23 protein expression (mean ± SD)
GroupsCasesExpression of nm23 protein (%)Intensity of nm23 protein
Positive to MSI86/8 (75.00)39.06 ± 2.14
Negative to MSI2210/22 (45.45)41.14 ± 2.36
Positive to LOH62/6 (33.33)41.23 ± 2.27
Negative to LOH2414/24 (58.33)39.44 ± 2.52